InsidersTradesSigma
Track the Neuralstem, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 28 January 2016 (Levée d'options). Among the most active insiders: GARR RICHARD. All data is openly available.
Analysts rate Neuralstem, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Neuralstem, Inc. is a biotechnology company focused on developing stem cell-based therapies for neurological diseases. It is listed on the NASDAQ under the ticker CUR.